Welcome to the community dedicated to personal safety, injury prevention and recovery. [What is InjuryBoard?]

Subscribe

RSS Feed

Add us to your favorite RSS reader

or subscribe by plain RSS

Archives

View previous posts from:

Defective Drugs | InjuryBoard New York City

The U.S. Food and Drug Administration (FDA) is researching data that shows an increased risk of cancer, in diabetic patients who use Regranex Topical Gel (becaplermin) for the treatment of foot and leg ulcers.The FDA received information from a study that was performed to investigate the possibility of increased cancer risk in connection with use of Regranex.The study was based on diabetic...

Posted by Chrissie Cole |
March 11, 2008 12:37 AM

The FDA has issued a safety alert regarding the proper use of Tussionex Extended-Release Suspension, a potent long acting prescription cough medication, following several reports of adverse events - including death - associated with inappropriate use.The medication contains hydrocodone (a narcotic) and chlorpheniramine (an antihistamine) and is prescribed for use in adults and children six years...

Posted by Chrissie Cole |
January 25, 2008 12:38 AM

The U.S. Food and Drug Administration (FDA) announced a nationwide drug recall of all lots of heparin and saline pre-filled flush syringes manufactured by AM2 PAT, Inc. under the brand name(s) Sierra Pre-filled, Inc. and B. Braun. The recall was announced after samples tested positive for Serratia marcescens, a bacterium that can cause death and serious injury. Serratia marcescens has been...

Posted by Shannon Weidemann |
January 20, 2008 10:23 AM

A study in the New England Journal of Medicine is reporting that many antidepressants do not work. The antidepressant study was performed by researchers at Oregon Health and Science University. They based their data on 74 studies that had been submitted to the FDA. The study shows that of the 74 studies registered with the Food and Drug Administration from 1987 through 2004, 38 were deemed...

Posted by Shannon Weidemann |
December 21, 2007 12:01 PM

The anti-bleeding drug Trasylol was recalled in early November after a study revealed the risk of death was 50 percent higher than on other drugs. The BART study examined results on over 3,000 patients that had been given Trasylol and two similar drugs. The Commission on Human Medicine decided this week to suspend Trasylol's license. The CHM decision to suspend the licence was made on the...

Posted by Shannon Weidemann |
December 19, 2007 9:54 PM

Pre-filled syringes manufactured by Sierra Pre-Filled have been recalled after being contaminated with Serratia marcescens. The recalled syringes had sicked approximately 40 people in two states. It is not known if the contaminated item was the syringe or the Heparin contained in them. Syringes from that batch also were sent to Colorado, Florida and Pennsylvania but infections so far have...

Posted by Shannon Weidemann |
November 14, 2007 9:48 PM

The vaccine Gardasil was introduced last year as a way to combat cervical cancer in women. It works by preventing an infection with Human Papilloma Virus (HPV). Now there are reports of girls having adverse affects after receiving the vaccine. One such report is from the family of a 12-year-old girl in Florida that had paralysis in one leg two weeks after receiving the first injection. The...

Posted by Shannon Weidemann |
November 05, 2007 8:51 PM

The blood clotting drug Trasylol will no longer be sold by Bayer AG after studies have shown there is an increased risk of death from using the drug. The recalled drug increases the risk of kidney damage when used during heart bypass surgery. The FDA cannot identify a patient population in which the use of Trasylol (aprotinin) outweighs the risk, Dr. John K. Jenkins, director of the FDA's...

Dialysis cartridges used in the NxStage's System One portable dialysis machine have been recalled due to potential dialysate leaks. The dialysis machines are used in 265 clinics around the country. After discussing the leakage issue with the U.S. Food and Drug Administration, NxStage said in the SEC filing that it decided on August 24 to physically recall the affected lots of cartridge...

The FDA issued a letter to Eli Lilly requesting more information about their drug Symbyax before approving it for a new use. Symbyax is a combination of Prozac and Zyprexa. Zyprexa is currently the subject of several state-led class action lawsuits due to underreported side effects and marketing of the drug for uses not approved by the FDA. The FDA made its request for more information on...

Posted by Jenny Albano |
July 11, 2007 8:45 PM

A Canadian women died in March due to toxic counterfeit drugs she purchased over the Internet. This was the first confirmed Canadian death due to Internet drugs. The women bought the bogus medication from a fake online pharmacy. The drugs she purchased were found to contain high levels of metal.The Executive Director of the Canadian Pharmacists Association (CPhA), Dr. Jeff Poston, is advising...

Two decades worth of studies were published recently in the Journal of the American Medical Association. The results show that as the cost of prescription drugs increase some patients stop use of their prescriptions and therapy. The findings were based on a review of 132 studies completed from 1985 to 2006."Such devices as higher co-payments, monthly limits and benefit caps are associated with...

Posted by Staff Writer |
June 13, 2007 11:03 AM

Families Argue Autism Link Before Vaccine Court On June 11, 2007 court proceedings began for cases involving mercury-containing preservative thimerosal in vaccines. More than 4,800 claims have been made by families of autistic children alleging that thimerosal caused their children's autism. These families will have to go before a special "Vaccine Court" and convince a panel of three judges...

GlaxoSmithKline settled for $64 million over a class-action lawsuit by parents whose children used antidepressant drug Paxil, the St. Louis Post-Dispatch reports.The defective drug Paxil has reportedly caused a significant increase in suicidal thinking in children and young people taking the drug for depression. There have also been suicides reported among those in this age group taking...

The FDA has issued a safety alert for the diabetes drug Avandia. The drug has been on the market for eight years and is used world wide. Avandia is manufactured by Glaxo. A study appeared in the New England Journal of Medicine that linked the drug with an increased rate of heart attack and death. The adverse drug reaction database has received approximately 28 Canadian reports of heart...

Brought to you by

The New York personal injury lawyers at Napoli Bern Ripka, LLP
Serving: New York City, Manhattan, Bronx, Brooklyn, Long Island, Nassau, Queens, Staten Island, Suffolk, Yonkers
350 5th Avenue
Suite 7413
New York, New York 10118

Attorneys

Paul Napoli
| Attorney
Napoli Bern Ripka, LLP
(866) 735-1102 Ext 300

Contact an Attorney

100% Private, 100% Confidential
Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship.

Regional Blogs